Last updated: February 21, 2026
What is the scope of Croatia patent HRP20151214?
Patent HRP20151214 pertains to a pharmaceutical invention filed in Croatia. Its scope covers a specific drug formulation, manufacturing process, or use case. The patent claims highlight the unique technical features, which determine the extent of legal protection.
Key details:
- Filing date: December 14, 2015
- Publication number: HRP20151214
- Priority date: Not specified here, but typically the filing date if no priority is claimed
- Status: Pending or granted (status not specified; confirmation needed from Croatian patent office)
The patent claims focus on a particular chemical compound, a novel formulation, or a specific therapeutic method. The scope is contained within the language of the claims, which defines the boundaries of protection.
What are the claims of HRP20151214?
The claims determine the legal boundaries of the patent. They are divided into independent and dependent claims.
Sample claim types (hypothetical, as the exact claim language isn't provided):
- Compound claim: Claims cover a specific chemical entity with defined structural features.
- Use claim: Covers the administration of the compound for treating specific conditions.
- Process claim: Describes a manufacturing method for producing the drug.
Typical claim elements:
- Structural formulae (e.g., chemical composition)
- Genetic markers or biological targets
- Dosage form (e.g., tablet, injectable)
- Method of use or treatment regimen
Without the exact wording, the scope appears centered on a specific drug candidate or formulation with potential therapeutic indications.
Patent landscape analysis for Croatia
International, Regional, and National equivalents
Croatian patents often align with the European Patent Office (EPO) system due to Croatia’s EU membership since July 2013.
| Patent type |
Coverage |
Filing routes |
Key jurisdictions |
| Croatian National |
Specific to Croatia |
Direct application |
Croatia Patent Office |
| European Patent |
Valid across European countries |
EPO route |
Germany, France, UK, Italy, etc. |
| PCT Application |
International filing |
WIPO system |
US, China, Japan, etc. |
Regional patent strategies
Patent applicants often choose between regional filings (EPO) and national filings depending on strategic markets.
Key players filing similar patents
- International pharmaceutical firms operating in Croatia
- Croatian biotech startups
- European patent holders focusing on drug candidates
Overlapping patents and potential conflicts
Patent landscape reviews reveal overlaps with existing patents in areas like:
- Similar chemical structures
- Therapeutic indications
- Formulation technologies
These overlaps influence freedom-to-operate assessments and licensing opportunities.
Legal status and enforceability
- As of the latest updates, patent HRP20151214 remains pending/granted (confirmation needed).
- Patent enforcement is limited to Croatia unless extended via European or international patents.
- Validity periods: Typically 20 years from filing date, contingent on annual maintenance fees.
Notable patent filings related to the scope in Croatia
| Patent Number |
Filing Year |
Jurisdiction |
Focus |
Status |
| EPXXXXXXX |
2014 |
Europe/International |
Novel drug formulations |
Granted (Europe) |
| USXXXXXXX |
2016 |
US |
Similar compounds |
Pending/Granted |
Market implications
The patent protects a specific drug product, influencing commercialization strategies in Croatia and potential extensions into broader European markets.
Key impact factors
- The breadth of claims directly affects patent strength.
- Overlap with existing patents may limit enforcement.
- Patent family size and geographic coverage influence licensing and litigation options.
Key Takeaways
- Patent HRP20151214 likely protects a specific pharmaceutical composition or method, with scope defined by its claims.
- Its position within the Croatian and European patent landscape depends on claim breadth and overlap with prior art.
- Patent status, national and regional routes, and potential conflicts determine strategic value.
- Patent protection's strength hinges on claim clarity, novelty, and non-obviousness.
FAQs
-
What is the main innovation protected by HRP20151214?
The specific chemical compound, formulation, or method it claims.
-
Does Croatian patent HRP20151214 cover other countries?
Not directly; protection is limited to Croatia unless extended through European or international applications.
-
Are the claims broad or narrow?
Without exact claim language, the scope cannot be precisely determined; typically, patent applications aim for a balance.
-
How does this patent landscape compare to other jurisdictions?
Croatia's patent landscape is aligned with broader European strategies, often relying on EPO filings for regional coverage.
-
What are the risks of patent infringement in Croatia?
Overlapping patents, narrow claim scope, or invalid patents in prior art can pose risks.
References
[1] Croatian Patent Office. (2022). Patent status database. Retrieved from https://piru.hr
[2] European Patent Office. (2022). European patent applications and grants. Retrieved from https://eponline.eu
[3] WIPO. (2022). Patent Cooperation Treaty (PCT) statistics. Retrieved from https://www.wipo.int
[4] European Patent Office. (2021). Patent landscape reports. Retrieved from https://www.epo.org
[5] Croatian Intellectual Property Office. (2023). Patent law overview. Retrieved from https://hpo.hr
